Skip to Main Content

Paper Details

Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study.
J Clin Oncol
76
2020
EGFR, EGFR mutations, EGFRvIII, GBM, GBMs, IDH, IDH WT, IDH Wild, IDH wild, MGMT, MGMT promoter, TERT, cancer, genes, glioblastoma, patients, primary tumor, temozolomide, tumor, tumors
Author NameAffiliation
Marc SansonSorbonne Universite
Johan M KrosErasmus University Medical Center
Roel G W Verhaak
Roel G W Verhaak
Ultan McDermottWellcome Sanger Institute
Pim J FrenchErasmus University Medical Center
  • 1 - 6

Datasets

Release 1.2